On Saturday we place our focus on Roszdravnadzor’s new recommendations regarding the use of the MDLP system by the pharmaceutical industry. The document which offers clarifications on six cases that are the most typical for entities participating in the circulation of drugs involving labelled and non-labelled drugs was published on September 10 this year.